Biocon Biologics to get Rs 225 cr from Tata Capital Growth Fund for 0.85 per cent equity stake Read more
Piramal Pharma Solutions to provide Bolt Biotherapeutics with immune-stimulating antibody conjugates and sterile fill-finish Read more
DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand Read more